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Abstract
Objective—To develop an ex vivo equine corneal organ culture model. Specifically, to assess the 
equine cornea's extracellular matrix and cellularity after 7 days using two different culture 
techniques: either (a) immersion system or (b) air/liquid interface system, to determine the best ex 
vivo equine corneal model.
Methods—Fourteen healthy equine corneas with 2 mm of perilimbal sclera were freshly 
harvested from 7 horses undergoing humane euthanasia. One corneal-scleral ring (CSR) from each 
horse was randomly placed in the (a) immersion condition organ culture system (IC), with the 
contralateral SCR being placed in the (b) air/liquid interface organ culture system (ALC) for 7 
days. All corneas were evaluated using serial daily gross photography, histology, qPCR and 
TUNEL assay.
Results—CSRs placed in the IC (a) had complete loss of corneal transparency on gross 
photography by 7 days, showed a significant level of corneal stromal disorganization, significantly 
increased αSMA levels on qPCR, and apoptosis on TUNEL assay compared to controls. The ALC 
(b), had weak stromal disorganization on histopathologic examination and was not significantly 
different from normal equine corneal controls on all other evaluated parameters.
Conclusions—The air-liquid interface organ culture system maintains the equine cornea's 
extracellular matrix and preserves corneal transparency, while the immersion condition results in 
near complete degradation of normal equine corneal architecture after 7 days in culture. The air-
liquid organ culture is a viable option to maintain a healthy equine cornea in an ex-vivo setting for 
wound healing studies.
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Introduction
Corneal disease in horses includes ulcerative, fungal, traumatic, and neoplastic conditions 
[1]. While these diseases are currently treated with a variety of medical and surgical 
modalities, permanent vision loss commonly results due to extensive corneal fibrosis.
Equine corneal research to date has typically been performed using either in vitro model 
systems [1-6] or in vivo studies utilizing a low number of animals [7-9]. In vitro models 
utilize monocultures of representative corneal cell populations and cannot fully evaluate 
potential pathologic and toxic changes that may occur in the multi-layered cornea. In vivo 
studies that contain small sample sizes may fail to prove significance due to low statistical 
power. It is desirable for in vitro research to be validated in vivo prior to routine clinical 
application of a new treatment. As such, ex vivo models represent a valuable bridge between 
in vitro and in vivo research.
Ex vivo models have been used to study a variety of different ocular diseases [10-16] in 
different species [14, 17-19]. One important benefit of an ex vivo model is that it allows for 
a more adequate representation of in vivo conditions. Successful corneal ex vivo models 
maintain normal corneal architecture, extra-cellular matrix, and different cell populations 
normally present within the living cornea. Additionally, ex vivo models are financially 
prudent, highly reproducible, and often require less regulatory approval when compared to 
in vivo experiments.
To our knowledge, no ex vivo model for the equine cornea exists. The goal of this study was 
to develop an ex vivo equine corneal model that would be highly reproducible. Two different 
types of ex vivo model systems were selected for study due to their previous successful use 
in other animals [17, 20, 21]. We sought to examine an immersion organ culture system (IC) 
or an air/liquid interface organ culture system (ALC). We hypothesized that ALC would be 
superior at preserving normal equine corneal architecture and demonstrate minimal cellular 
apoptosis when compared to the IC.
Materials and Methods
Approval for this study was obtained by the University of Missouri Institutional Animal 
Care and Use Committee. A total of seven horses donated to the University of Missouri were 
humanely euthanized for reasons unrelated to this study. The median age of all horses was 
17 years (range 14-22 years). Breeds included 4 Quarter horses, 2 Appaloosas and 1 
Belgian. Prior to euthanasia, all horses had slit-lamp biomicroscopy (SL-15 Biomicroscope, 
Kowa Inc, Tokyo, Japan) performed OU by a board-certified veterinary ophthalmologist 
(EAG) and were deemed free of anterior segment disease.
Immediately following humane euthanasia, the ocular surface was washed with a 1% dilute 
betadine solution. The cornea along with the surrounding 2-3 mm of peri-limbal sclera was 
harvested by making a stab incision into the sclera with a Bard-Parker #11 blade (Aspen 
Surgical, Caledonia, MI) and then continuing the incision around the peri-limbal sclera with 
Stevens tenotomy scissors (Integra Miltex, Plainsboro, NJ). Once the cornea and 
surrounding sclera (corneal-scleral ring, CSR) was harvested, the CSRs were immediately 
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placed into a sterile 50 ml test tube filled with 20 ml of modified eagle medium (Life 
technologies, Carlsbad, CA), placed on ice, and promptly transported to the laboratory. Once 
at the laboratory, the test tube was opened under a cell culture hood and the contents placed 
into a sterile petri dish. Any remaining peri-limbal conjunctiva was removed at that time 
with sterile Stevens tenotomy scissors and the CSR was again washed with a 1% betadine 
solution followed by copious rinsing with sterile phosphate buffer solution (PBS). A coin 
toss was utilized to randomly assign the CSRs into one of two culture systems (e.g. IC or 
ALC).
For the IC, the CSR was sterilely placed into a 50 ml tissue culture plate (Corning Life 
Sciences, Corning, NY) epithelial side up. The tissue culture plate was then filled with 15 
mls of MEM media supplemented with 10% fetal bovine serum, essential amino acids, 
penicillin, streptomycin, fungizone, sodium pyruvate and MEM vitamins. All culture media 
reagents were provided by Life technologies Carlsbad, California. Following application of 
media the CSR was visibly inspected to ensure it was completely submerged. The total 
culture media was changed once daily.
For the ALC, the CSR was placed onto a specially constructed corneal conformer (Figure 1) 
that was designed to maintain the normal corneal curvature of the equine cornea without 
appling any unequal force to the corneal endothelium. The CSR and conformer were placed 
into a 50 ml tissue culture plate, 13 mls of culture media was added such that the corneal 
endothelium was continually bathed in culture media but a 10 mm diameter area of axial 
equine cornea was exposed to air. Media was changed daily and the exposed axial cornea 
received one drop of media three times daily (every 8 hours) to prevent corneal desiccation.
All CSRs were cultured at 37° C in 5% CO2 for 7 days. CSRs were evaluated daily for gross 
evidence of either bacterial or fungal contamination, and were photographed. After 7 days in 
culture, the CSRs from both model systems were sectioned and one half placed into 10% 
neutral buffered formalin for histological analysis and the other half frozen with optimal 
cutting medium and placed in −80°C until further analysis was performed. All model system 
corneas were compared histologically, through TUNEL assay, and by qPCR against healthy 
corneas from 4 normal control horses that were humanely euthanized for reasons other than 
ocular disease and processed immediately after harvesting.
Corneal Transparency
Gross photography was performed daily using a Nikon D300s camera (Nikon, Melville, 
New York). Corneal transparency of both model systems was evaluated by placing CSRs 
into a sterile petri dish and then placing the sterile petri dish over a single line of 11 point 
Arial font. The corneas were determined to be “opaque” (lost all corneal transparency) when 
the font was no longer able to be read through the axial stroma [17].
Histopathologic Evaluation
Corneal sections were routinely processed for histological evaluation with haematoxylin and 
eosin staining. All sections were evaluated by the primary author (TM) and graded by using 
a scale similar to that utilized in Janin et. al where 0=no stromal disorganization, 1=weak 
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stromal disorganization, 2=moderate stromal disorganization, 3=strong stromal 
disorganization [17].
Real-time polymerase chain reaction detection (qPCR)
At study end-point, sections of axial cornea weighing 1 gram or less were taken from all 
CSRs in both models and individually frozen at −80°C until total RNA could be extracted. 
For RNA extraction, each sample of cornea was placed into liquid nitrogen with 500 μl RLT 
buffer (RNeasy kit , Qiagen, Valencia, CA) and 1% β-mercaptoethanol. This mixture was 
then ground into a fine powder using a mortar and pestle, placed in a QIAshredder column 
(RNeasy kit, Qiagen, Valencia, CA) on ice and processed according to manufacturer's 
instructions. All corneas had qPCR performed evaluating for α-SMA. The forward primer 
for α-SMA was TGGGTGACGAAGCACAGAGC and the reverse primer was 
CTTCAGGGGCAACACGAAGC. This procedure was performed using a Step One Plus 
real-time PCR system (Applied Biosystems, Carlsbad, CA, USA) utilizing a 20 μl mixture 
containing 2 μl cDNA, 2 μl forward (200 nM) and 2 μl reverse (200 nM) primer, and 10 μl of 
2X SYBR green super mix (Bio-Rad Laboratories, Hercules, CA). This master mix was 
performed at a universal cycle (95 °C for 10 min, 40 cycles at 95 °C for 15 s, and 60 °C for 
60 s) according to the manufacturer's instructions [22]. β-actin was used as the housekeeping 
gene with the forward primer being CGGCTACAGCTTCACCACCA and the reverse primer 
being CGGGCAGCTCGTAGCTCTTC. These primers had previously been validated on 
equine corneal cells [1, 4]. The efficacy of each primer was determined by using each PCR 
primers expression ratio. From this, a fold change was then calculated using the 2−ΔΔCT 
ratio.
TUNEL Analysis
A TUNEL kit (ApopTag Plus In Situ Apoptosis Fluorescein Detection Kit; Millipore, 
Billerica, MA) was utilized for all TUNEL testing in accordance with manufacturer's 
instructions [23, 24]. Briefly, all tissue sections had an application of equilibrium buffer 
followed by an application of TdT enzyme which was incubated together with the corneal 
cryosection for 1 hour at 37°C in a humidified chamber. These corneal cryosections then had 
an application of the stop solution consisting of Apop taq R mixed with water, followed by a 
PBS wash. Anti-digoxigenin Rhodamine was applied and the slides were counterstained 
with Vectashield Mounting Medium containing DAPI (Vector labs, United Kingdom) [24]. 
The number of cells exhibiting apoptosis as indicated by having a red nucleoli on 
fluorescence were counted in 5 10x fields per corneal cryosection and averaged for statistical 
analysis.
Statistical Analysis
A Mann-Whitney test was used to determine significance for all gross photography and 
histologic results. Statistical analysis of PCR and TUNEL data was performed using a one-
way ANOVA and Tuckey's test. A P-value of equal to or less than 0.05 was considered 
significant.
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Results
Corneal Transparency
Analysis of corneal transparency was determined if A) the sample was still transparent 
yielding a value of 0 for statistical analysis or B) the sample was opaque (unable to clearly 
visualize the Arial font) and therefore given a value of 1. At the end of the culture period all 
corneas in the IC had a uniform loss of corneal transparency (Figure 2). This was in stark 
contrast to corneas in ALC which ubiquitously maintained the natural transparent state of 
the equine cornea. Differences between the IC and the ALC were significant (p<0.01).
Histological Evaluation
Histological evaluation of all healthy control corneas yielded a grade 0. IC corneas 
uniformly had complete loss of the corneal epithelium, breaks in descemet's membrane and 
severe corneal edema (grade 3) which resulted in an overall loss of the normal corneal 
architecture (Figure 3b). Histological evaluation of ALC corneas yielded the following: 3 
receiving a grade 0, and 4 receiving a grade 1. For grade 1 corneas there was mild corneal 
edema which minimally disrupted the corneal architecture (Figure 3c). Corneas from the 
ALC (both grade 0 and grade 1) had both their corneal epithelium and endothelium intact at 
the end of the culture period. A significant difference between IC corneas was detected 
between both controls (p<0.01) and ALC corneas (p<0.01). No significant difference 
between the ALC model and control group corneas was identified (p=0.073).
Real-time PCR
Real-time PCR was performed on all samples evaluating for α-SMA. IC corneas showed a 
significant increase in α-SMA levels in comparison to controls (p<0.01). The magnitude of 
this increase was levels of α-SMA nearly seven times higher than that found in healthy 
control corneas. Significantly increased α-SMA levels were found in IC corneas when 
compared to the ALC corneas (p<0.01). Corneas from the ALC had higher α-SMA levels 
than controls, but the results were not significant (p=0.749) (Figure 4).
TUNEL
On TUNEL evaluation an increased level of cellular apoptosis was found in IC corneas 
(Figure 5b) compared to controls (Figure 5a), these results were significant (p<0.01) Results 
of ALC corneas (Figure 5c) and control corneas showed no significant difference (p=0.899).
Discussion
Our data suggests that the air-liquid interface organ culture system better preserves the 
equine cornea when compared to the immersion condition organ culture system. We were 
able to adequately maintain the integrity of the equine corneal epithelium, stroma, and 
endothelium using the ALC with only minimal corneal edema present at study endpoint. By 
contrast, corneas in the IC had severe distortion of both the cellular and extracellular 
components of the equine cornea which resulted in a complete loss of corneal transparency 
and overall corneal architecture.
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Since the corneal epithelial cells are nourished through the ocular tear film, one of the main 
challenges of any ex vivo corneal model is mimicking the constant blinking that allows for 
uniform distribution of the pre-corneal tear film. Previous studies have tried to resolve this 
issue by either developing a mechanical means of mimicking blinking through the use of a 
superfusion apparatus [25]. With the use of this machine the investigator is able to maintain 
a desired temperature, the corneas exposure to media, and artificial tear flow all while in a 
sterile environment. Other investigators have developed mechanical arms allowing for the 
eyelid to be pulled over the cornea after a drop was administered to mimic a blink [26]. 
Another route of maintaining adequate nutrition to the corneal epithelium is by placing the 
entire model on a rocker that allows for the organ culture media to periodically flow over the 
entire cornea at a desired rate [20]. In the paper by Deshpande et. al it was shown that 
rocking media over the entire cornea allowed for an extension of the model's life by up to 4 
weeks when compared to static controls that only received a topical application of media 
once daily. This current study differed from this afore mentioned study, as we elected to treat 
the air/liquid cornea multiple times a day, thereby providing more nutrition to the corneal 
epithelium and preventing corneal desiccation. While we cannot directly compare our study 
which was a week in duration and in a different animal species with the study that was 4 
weeks in duration [20], on histopathologic evaluation we found similar results with regards 
to overall corneal architecture and thickness of the corneal epithelium.
While the IC has been utilized for human limbal cell culture models [21], our study results 
do not support the use of this model for a complete equine corneal ex vivo model system. 
The corneal stroma is maintained in a state of relative detrugesence through the corneal 
epithelium and endothelium providing a barrier to fluid entering into the cornea and the 
corneal endothelium utilizes a Na+/K+ pump to efficiently remove fluid from the corneal 
storma [27]. In all IC corneas there was a relative absence of corneal epithelium, which 
likely resulted in the corneal stroma being constantly exposed to the organ culture media. 
Cottlier described that a loss of either the corneal epithelium or endothelium resulted in a 
200% or 500% increase in corneal thickness, respectively [28]. The severe corneal edema 
we observed resulted in overall loss of gross transparency in all IC corneas. The loss of the 
epithelium seen in this study likely also initiated the multifaceted process of corneal wound 
healing. This could explain the nearly seven fold increase in α-SMA, a known cellular 
cytokine indicative of corneal fibroblast to myofibroblast transformation [29] when 
compared to controls.
A common problem with corneal ex vivo model systems is that while they include all layers 
of the cornea and the extracellular matrix, damage to the fragile corneal endothelium is not 
uncommon with time. In the ex vivo ALC model described in this paper, we noted that as 
with other published corneal ex vivo model systems, there was some histological evidence of 
endothelial damage where the corneal conformer directly contacted the corneal endothelium. 
However, in the axial cornea of the ALC group the corneal endothelium did not appear 
broken or damaged and was still attached to Descemet's membrane on histopathology. 
Additionally, the corneal endothelium did not have a significant positive fluorescence on 
TUNEL assay indicating minimal apoptosis was present at study endpoint. Our ALC model 
system for equine corneas appears to afford similar endothelial protection as observed in 
other successful ex vivo models in various species [14, 30].
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Ex vivo corneal models have been utilized to study a variety of different diseases in both 
veterinary and physician ophthalmology. A recent paper by Harman et. al utilized a similar 
ALC canine corneal model to study acute keratitis from a CHV-1 outbreak [18]. Another 
paper by Bhasker et. al examined the use of a bovine ex vivo model to evaluate the 
protective effects of nanoformulated therapeutics [19]. In physician ophthalmology there is a 
move to eliminate the Draize test due to animal welfare concerns [31]. As a result there is a 
rise in the use of ex vivo corneal models used to study the effects of different compounds on 
the eye [10]. Our goal is to utilize the best possible equine corneal ex vivo model to study 
equine corneal disease. Our laboratory currently has experiments underway evaluating the 
fibrotic response of ex vivo equine corneas after applying an alkaline burn. Other potential 
applications of the ALC model include the investigation of different topical treatments for 
bacterial or fungal keratitis. Finally, this equine ex vivo model could be used to determine 
different corneal drug toxicities prior to direct application.
Our data indicates that the IC is an inappropriate model to study the equine cornea due to 
rapid corneal deterioration. By contrast, the ALC preserves near normal equine corneal 
structure and function for 7 days. Future studies aimed at utilizing the ALC ex vivo model to 
study equine corneal fibrosis are currently underway by our laboratory.
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Figure 1. 
Plastic conformer utilized for ALC in our study. Given the large size of the equine cornea, 
we found this conformer helpful in maintaining the normal corneal curvature.
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Figure 2. 
Photo documentation of equine corneal transparency. (A) ALC cornea Day 0; (B) IC cornea 
Day 0; (C) ALC cornea Day 7; (D) IC cornea Day 7; Notice that the IC cornea has near 
complete loss of transparency, while the ALC cornea has good preservation of corneal 
transparency at study endpoint.
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Figure 3. 
Representative histological corneal images stained with H & E staining: (A) Healthy equine 
corneal control; (B) IC cornea on day 7. Complete loss of corneal epithelium along with 
severe stromal edema; (C) ALC cornea on day 7; corneal epithelium is still intact and only 
mild to moderate corneal edema is present.
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Figure 4. 
Graph representing mRNA values from PCR of a-Smooth Muscle Actin (error bars indicate 
standard deviation). Note that both the control and ALC corneas are similar in value while 
the IC cornea had significantly higher aSMA values.
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Figure 5. 
Representative corneal images stained by TUNEL assay. (A) Healthy control; (B) IC cornea 
on Day 7; note the large areas of red nuclei indicating apoptotic bodies. (C) ALC cornea on 
Day 7; note that the cornea is minimally affected with apoptotic bodies.
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